TABLE 6.
Observation on clinical effect of Qingfei Paidu prescription with different dosage forms in the treatment of COVID-19.
| No | The number of cases | Pharmaceutical dosage form | Course of treatment | Cure rate (%) | Total effective rate (%) | Province | References |
| 1 | 76 cases | Granules | 5 days as a course of treatment, three courses of treatment | 65.79% | 88.16% | Hubei province | Hu et al. (2020) |
| 2 | 98 cases | Decoction | 3 days as a course of treatment, three courses of treatment | 41.13% | 92.09% | Sichuan province | Wang et al., 2020b |
| 3 | 30 cases | Decoction | 3 days as a course of treatment, three courses of treatment | NA | 83.335 | Hubei province | Li et al., 2020b |
| 4 | 151 cases | Mixture | 3 days as a course of treatment, three courses of treatment | 43.70% | 90.07% | Sichuan province | Lai et al. (2020) |
| 5 | 108 cases | Decoction | 3 days as a course of treatment, three courses of treatment | NA | 91.67% | Hubei province | Meng et al. (2020) |
| 6 | 214 cases | Decoction | 3 days as a course of treatment, three courses of treatment | NA | 90% | Shanxi, Hebei, Shaanxi, Heilongjiang province |
General Office of National Health Commission, State Administration of Traditional Chinese Medicine (2020) |